Targeted inhibition of hepatic de novo ceramide synthesis ameliorates MASH
Science Advances · 26.09.2025 · 11 (39)
DOI: 10.1126/sciadv.adx2681 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 26.09.2025. Verfasst von Xiaodong Yu und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore. Hauptthemen laut MEDLINE: Ceramides, Liver, Fatty Liver. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Increasing evidence implicates ceramides in the pathogenesis of metabolic dysfunction-associated steatohepatitis (MASH). However, the therapeutic potential of liver-targeted ceramide lowering remains unclear. In this study, we demonstrate that elevated ceramide levels in MASH patients and mouse models are closely associated with the activation of hepatic de novo ceramide synthesis. The analysis of human hepatic single-nucleus RNA sequencing (snRNA-seq) data revealed predominant up-regulation of SPTLC2 , which encodes a subunit of the rate-limiting enzyme in the de novo ceramide synthesis pathway, in hepatocytes. By targeted inhibition of SPTLC2 with lipid nanoparticle–mediated siRNA delivery to hepatocytes, we reduced both hepatic and circulating ceramide levels. This intervention suppressed hepatic lipid uptake and lipogenesis, thereby alleviating MASH progression. Therapeutic efficacy was demonstrated in an 8-week methionine-choline–deficient diet-induced MASH model and validated in a 1-year choline-deficient high-fat diet–induced MASH model. Our findings highlight hepatocyte Sptlc2 as a promising therapeutic target for MASH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
- Nanomedicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117609, Singapore.
- Cardiovascular Research Institute, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.
- CDL Research, UMC Utrecht, Utrecht, Netherlands.
- Department of Chemical and Biomolecular Engineering, National University of Singapore, Singapore 117585, Singapore.
- Institute of Translational Medicine Medical College, Yangzhou University, Yangzhou, Jiangsu 225001, China.
ORCID-Profile: Chenyuan Huang, Martijn Evers, Jingjing Liu, Hui Jun Ting, Sitong Zhang, Suet Yen Chong, Nilofer Sayed, Liang Gao, Mark D Muthiah, Gwyneth S T Soon, Aileen Wee, Edward Kai-Hua Chow, Natalie Jun Hui Soh, Giorgia Pastorin, Victor C Yu, Bin Liu, Yock Young Dan, Raymond Schiffelers, Jiong-Wei Wang
Zitieren
APA
Yu, X., Huang, C., Evers, M., Liu, J., Ting, H. J., Zhang, S., Chong, S. Y., Tan, M. S., Wang, S., Sayed, N., Gao, L., Muthiah, M. D., Soon, G. S. T., Wee, A., Chow, E. K., Soh, N. J. H., Pastorin, G., Yu, V. C., Liu, B., …, & Wang, J. W. (2025). Targeted inhibition of hepatic de novo ceramide synthesis ameliorates MASH. Science Advances, 11(39). https://doi.org/10.1126/sciadv.adx2681
Vancouver
Yu X, Huang C, Evers M, Liu J, Ting HJ, Zhang S, et al. Targeted inhibition of hepatic de novo ceramide synthesis ameliorates MASH. Science Advances. 2025;11(39). doi:10.1126/sciadv.adx2681
BibTeX
@article{Yu2025,
author = {Yu, Xiaodong and Huang, Chenyuan and Evers, Martijn and Liu, Jingjing and Ting, Hui Jun and Zhang, Sitong and Chong, Suet Yen and Tan, Michelle Siying and Wang, Siyu and Sayed, Nilofer and Gao, Liang and Muthiah, Mark D and Soon, Gwyneth S T and Wee, Aileen and Chow, Edward Kai-Hua and Soh, Natalie Jun Hui and Pastorin, Giorgia and Yu, Victor C and Liu, Bin and Dan, Yock Young and Torta, Federico and Schiffelers, Raymond and Storm, Gert and Wang, Jiong-Wei},
title = {Targeted inhibition of hepatic de novo ceramide synthesis ameliorates MASH},
journal = {Science Advances},
year = {2025},
volume = {11},
number = {39},
doi = {10.1126/sciadv.adx2681}
}
EUVIMED